Nabeel Mohammad Qasem
Nabeel Mohammad Qasem publishes mostly in Hematology, Genetics and Pathology and Forensic Medicine, on topics such as Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research and Myeloproliferative Neoplasms: Diagnosis and Treatment.
- World rank
- #4,998,377 of 7,710,434 ranked researchers
- Rank in Qatar
- #2,595 of 3,423
- Works
- 22
- Citations
- 43
- Citations per work
- 2.0
What does Nabeel Mohammad Qasem research?
Nabeel Mohammad Qasem's work is mostly in Medicine (55%), Biochemistry, Genetics and Molecular Biology (4%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1254.6%
- Medicine1254.6%
- Everything else836.4%
- Life Sciences29.0%
- 1Hematology24% of their works
- 2Genetics17% of their works
- 3Pathology and Forensic Medicine8% of their works
- 4Rheumatology6% of their works
- 5Immunology4% of their works
- 6Molecular Biology4% of their works
Research topics
- Chronic Myeloid Leukemia Treatments
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Acute Myeloid Leukemia Research
- Chemotherapy-induced organ toxicity mitigation
- Eosinophilic Disorders and Syndromes
- Retinoids in leukemia and cellular processes
- Immunodeficiency and Autoimmune Disorders
Which keywords describe Nabeel Mohammad Qasem's research?
The keywords of their largest research topics: Prognostic Factors, BCR-ABL, Imatinib, Acute Myeloid Leukemia, AML, Chronic Lymphocytic Leukemia, Genomic Aberrations and JAK2 Mutation.
- Primary Immunodeficiency
- Acute Promyelocytic Leukemia
- Hypereosinophilic Syndrome
- Cisplatin
- JAK2 Mutation
- Chronic Lymphocytic Leukemia
- AML
- BCR-ABL
- Prognostic Factors
- Imatinib
- Acute Myeloid Leukemia
- Genomic Aberrations
- Myelofibrosis
- Fusion Genes
- Nephrotoxicity
- Genetic Mutations
- Retinoic Acid
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 17 words, with their numbers
- Prognostic Factors102 topics
- BCR-ABL81 topic
- Imatinib81 topic
- AML51 topic
- Acute Myeloid Leukemia51 topic
- Chronic Lymphocytic Leukemia51 topic
- Genomic Aberrations51 topic
- JAK2 Mutation51 topic
- Myelofibrosis51 topic
- Cisplatin31 topic
- Fusion Genes31 topic
- Hypereosinophilic Syndrome31 topic
- Nephrotoxicity31 topic
- Acute Promyelocytic Leukemia21 topic
- Genetic Mutations21 topic
- Primary Immunodeficiency21 topic
- Retinoic Acid21 topic
Where does Nabeel Mohammad Qasem work?
Nabeel Mohammad Qasem's main affiliation in the publication record is Hamad Medical Corporation, Qatar.
How many publications and citations does Nabeel Mohammad Qasem have?
OpenAlex counts 22 works and 43 citations for Nabeel Mohammad Qasem, an h-index of 3, ranking #4,998,377 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Nabeel Mohammad Qasem. Posts are plain text and can be reported.